Award Recognizes Technologies That Address Important Industry Needs and Advance Prior Standards BOTHELL, Wash., April 21, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading ...

Over the last 7 days, the United States market has risen by 1.7%, contributing to a remarkable 34% increase over the past year, with earnings anticipated to grow by 16% annually in the coming years.

BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...

BioLife Solutions (BLFS-2.70%) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 ...

In the preceding three months, 4 analysts have released ratings for BioLife Solns (NASDAQ:BLFS), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...

BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

BioLife Solutions focuses on cell- and gene-therapy preservation tools, used primarily by the biotech industry. The company did trim its losses, year over year, in the quarter. BioLife Solutions said ...

A blood plasma center that opened in Moorhead in April is drawing more donors than anticipated. When BioLife Plasma Services opened at 2960 12th St. S., it took in 250 donors a week. Now the center ...

BioLife CEO Bill Jones calls for a new global health vocabulary, shifting from weight-loss language to biology-driven terms that support metabolic well-being, body positivity, and regenerative care.

BioLife Plasma, a plasma donation center, opened its 200th U.S. location and first location in Pearland on March 25. The new plasma service center located at 3020 Kirby Drive is part of the ...

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced it has received the ...